Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALML3 | P27482 | 5/20 | 0.40 |
| ▸ | MAOA | P21397 | 8/20 | 0.40 |
| ▸ | MAOB | P27338 | 4/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | SDHA | P31040 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1769541 | 0.87 | SIGMAR1 (0.47) | SIGMAR1 | |
| SCHEMBL1769216 | 0.86 | CALML3 (0.52) | CALML3MAOAMAOBCYP3A4LMNA | |
| SCHEMBL1769446 | 0.85 | MAOB (0.43) | CALML3MAOAMAOBLMNAPTGS1 | |
| SCHEMBL1769559 | 0.80 | CALML3 (0.40) | CALML3MAOAMAOBCYP3A4CYP2D6 | |
| SCHEMBL16701317 | 0.78 | CALML3 (0.49) | CALML3MAOAMAOBCYP3A4CYP2D6 | |
| SCHEMBL16701320 | 0.78 | CALML3 (0.49) | CALML3MAOAMAOBCYP3A4CYP2D6 | |
| SCHEMBL7538108 | 0.78 | MAOA (0.47) | CALML3MAOAMAOBCYP3A4CYP2D6 | |
| SCHEMBL4574440 | 0.78 | CALML3 (0.47) | CALML3MAOAMAOBCYP3A4CYP2D6 | |
| SCHEMBL1769322 | 0.76 | F10 (0.67) | — | |
| SCHEMBL1034941 | 0.76 | CALML3 (0.47) | CALML3MAOAMAOBCYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011061760-A1 | NOVEL ANTITHROMBOTIC AGENTS | CADILA HEALTHCARE LIMITED (IN) | 2011-05-26 | — | — | WO | disclosed |